Baillie Gifford & CO Insmed Inc Transaction History

Baillie Gifford & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$16.26 - $21.73 $1,544 - $2,064	95 Added 13.44%	802 $13,000
Q3 2021 Oct 19, 2021	SELL	$22.46 - $29.47 $1,796 - $2,357	-80 Reduced 10.17%	707 $19,000
Q1 2021 May 06, 2021	BUY	$32.28 - $44.3 $871 - $1,196	27 Added 3.55%	787 $27,000
Q4 2020 Feb 10, 2021	BUY	$31.45 - $40.54 $23,902 - $30,810	760 New	760 $25,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.